These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37762390)

  • 21. Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome.
    Aqrawi LA; Chen X; Jensen JL; Morthen MK; Thiede B; Utheim ØA; Palm Ø; Tashbayev B; Utheim TP; Galtung HK
    PLoS One; 2018; 13(10):e0205762. PubMed ID: 30312344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. sPLA
    Wei Y; Asbell PA
    Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease.
    Sonawane S; Khanolkar V; Namavari A; Chaudhary S; Gandhi S; Tibrewal S; Jassim SH; Shaheen B; Hallak J; Horner JH; Newcomb M; Sarkar J; Jain S
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8253-63. PubMed ID: 23169882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry.
    Pieragostino D; Agnifili L; Cicalini I; Calienno R; Zucchelli M; Mastropasqua L; Sacchetta P; Del Boccio P; Rossi C
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Culture- and non-culture-based approaches reveal unique features of the ocular microbiome in dry eye patients.
    Naqvi M; Fineide F; Utheim TP; Charnock C
    Ocul Surf; 2024 Apr; 32():123-129. PubMed ID: 38354907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear biomarkers in dry eye disease: Progress in the last decade.
    Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TFOS DEWS II Tear Film Report.
    Willcox MDP; Argüeso P; Georgiev GA; Holopainen JM; Laurie GW; Millar TJ; Papas EB; Rolland JP; Schmidt TA; Stahl U; Suarez T; Subbaraman LN; Uçakhan OÖ; Jones L
    Ocul Surf; 2017 Jul; 15(3):366-403. PubMed ID: 28736338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconsidering the central role of mucins in dry eye and ocular surface diseases.
    Baudouin C; Rolando M; Benitez Del Castillo JM; Messmer EM; Figueiredo FC; Irkec M; Van Setten G; Labetoulle M
    Prog Retin Eye Res; 2019 Jul; 71():68-87. PubMed ID: 30471351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of dry eye disease and novel therapeutic targets.
    Messmer EM
    Exp Eye Res; 2022 Apr; 217():108944. PubMed ID: 35077753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
    Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
    Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome.
    Chang CJ; Somohano K; Zemsky C; Uhlemann AC; Liebmann J; Cioffi GA; Al-Aswad LA; Lynch SV; Winn BJ
    Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):32. PubMed ID: 36036910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormones and dry eye disease.
    Gorimanipalli B; Khamar P; Sethu S; Shetty R
    Indian J Ophthalmol; 2023 Apr; 71(4):1276-1284. PubMed ID: 37026259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Mucin-Deficient Ocular Surface Mimetic Platform for Interrogating Drug Effects on Biolubrication, Antiadhesion Properties, and Barrier Functionality.
    Madl AC; Liu C; Cirera-Salinas D; Fuller GG; Myung D
    ACS Appl Mater Interfaces; 2022 Apr; 14(16):18016-18030. PubMed ID: 35416028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of dry eye disease in the UK: The Aston dry eye study.
    Vidal-Rohr M; Craig JP; Davies LN; Wolffsohn JS
    Cont Lens Anterior Eye; 2023 Jun; 46(3):101837. PubMed ID: 37003925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tear Production Levels and Dry Eye Disease Severity in a Large Norwegian Cohort.
    Yazdani M; Chen X; Tashbayev B; Utheim ØA; Ræder S; Lagali N; Stojanovic A; Dartt DA; Utheim TP
    Curr Eye Res; 2018 Dec; 43(12):1465-1470. PubMed ID: 30183390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.